CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Cash flows from operating activities
Net loss	$ (20,084,554)	$ (4,731,072)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation expense	9,919	0
Loss on extinguishment of notes payable	5,643,607	0
Decrease in fair value of derivative liabilities	(783,129)	(539,467)
Amortization of discount on notes payable	883,125	353,009
Impairment of acquired contracts	686,350	0
Amortization of patents and acquired contracts	1,557,107	293,176
Stock-based compensation	2,873,396	1,872,104
Issuance of new stock in conjunction with the restricted stock granted	225,001	0
Changes in operating assets and liabilities
Accounts receivable	(259,049)	0
Inventories	12,207	0
Prepaid expenses and other current assets	(113,282)	(73,207)
Deposits and other assets	1,406	(20,399)
Accounts payable	906,835	602,564
Accrued expenses and other current liabilities	114,971	0
Accrued interest on notes payable	(6,935)	6,935
Warranty reserve	(38,143)	0
Net cash used in operating activities	(8,371,167)	(2,236,357)
Cash flows from investing activities
Purchases of property and equipment	(52,186)	0
Issuance of short-term note receivable, related party	(3,000,000)	0
Purchases of patents	0	(9,455,585)
Cash received in acquisition	790,172	0
Net cash used in investing activities	(2,262,014)	(9,455,585)
Cash flows from financing activities
Proceeds from issuance of common stock, net of issuance costs	6,021,144	3,612,100
Proceeds from issuance of convertible notes payable, net of issuance costs	3,371,834	4,950,000
Proceeds from issuance of notes payable	9,964,868	3,100,000
Proceeds from related party note payable	300,000	0
Payments on short-term notes payable, related party	(100,000)	0
Payments on convertible notes	(8,000,000)	0
Payments on guaranteed payment liability	(1,000,000)	0
Net cash provided by financing activities	10,557,846	13,210,626
Net increase in cash and cash equivalents	(75,335)	1,518,684
Cash and cash equivalents, beginning of year	1,518,684	0
Cash and cash equivalents, end of year	1,443,349	1,518,684
Supplemental disclosures of cash flow information
Cash paid for interest	516,919	0
Cash paid for income taxes	0	0
Supplemental disclosures of non-cash investing and financing activities
Convert outstanding LLC accrued liabilities to member contribution, January 2013	0	12,783
Allocation of fair value from Series A-2 redeemable convertible preferred stock to Series A-1 redeemable convertible preferred stock (See Note 7)	0	865,985
Allocation of fair value from notes payable to Series A-1 redeemable convertible preferred stock (See Note 6)	0	2,392,889
Fair value of notes payable redemption derivative liability	0	582,903
Fair value of Series A-1 redeemable convertible preferred stock anti-dilution derivative liability	0	548,465
Accrued guaranteed payments and deferred expenses associated with purchased patent assets	5,056,296	13,510,178
Offset of short-term related party notes payable and receivable	3,000,000	0
Fair value of convertible notes payable redemption derivative liability	0	534,975
Transfer of Series A redeemable convertible preferred stock to preferred stock	3,392,950	0
Series A-1 Redeemable Convertible Preferred Stock [Member]
Cash flows from operating activities
Net loss	0	0
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	0	50,000
Series A-2 Redeemable Convertible Preferred Stock [Member]
Cash flows from operating activities
Net loss	0	0
Cash flows from financing activities
Proceeds from issuance of redeemable convertible preferred stock	$ 0	$ 1,498,526